New safety issues plague Hep C antivirals
31st January 2017
US health authorities have identified hundreds of cases of acute liver failure in patients taking direct-acting antivirals (DAA) for hepatitis C.
Log In
Welcome to AusDoc.Plus, the new home of Australian Doctor, Medical Observer, 6minutes and How to Treat. You can use your existing login credentials for any of these sites to gain entry.
Not a member?
Join AusDoc.PLUS
Register
To ensure you get the right membership, please select your vocation: